Gene: AIF1L
Official Full Name: allograft inflammatory factor 1 likeprovided by HGNC
Gene Summary: Enables actin filament binding activity. Predicted to be involved in actin filament bundle assembly and ruffle assembly. Located in actin filament and focal adhesion. Biomarker of breast cancer. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25466 | AIF1L Knockout cell line (HeLa) | Human | AIF1L | 1:3~1:6 | Negative | Online Inquiry |
KO25467 | AIF1L Knockout cell line (HCT 116) | Human | AIF1L | 1:2~1:4 | Negative | Online Inquiry |
KO25468 | AIF1L Knockout cell line (HEK293) | Human | AIF1L | 1:3~1:6 | Negative | Online Inquiry |
KO25469 | AIF1L Knockout cell line (A549) | Human | AIF1L | 1:3~1:4 | Negative | Online Inquiry |
AIF1L Gene Knockout Cell Lines represent a significant advancement in the field of genetic research, specifically designed to facilitate the study of the Apoptosis-Inducing Factor 1-Like (AIF1L) gene and its associated pathways. These cell lines contain targeted deletions of the AIF1L gene, allowing researchers to investigate the role of this gene in cellular processes such as apoptosis, mitochondrial function, and immune responses without the confounding effects of gene expression.
The mechanisms underlying the function of AIF1L are critical to understanding its contributions to various biological systems. By employing these knockout cell lines, scientists can elucidate the consequences of AIF1L deficiency on cell viability, cytokine production, and stress responses. This provides insights not only into basic biology but also into pathological states such as neurodegeneration and inflammation, where AIF1L is believed to have significant roles.
From a scientific standpoint, the importance of AIF1L Gene Knockout Cell Lines in both research and clinical settings cannot be overstated. They are invaluable for generating data that can lead to therapeutic strategies aimed at modulating AIF1L function in diseases like cancer and autoimmune disorders. Experimenting with these cell lines allows for a deeper understanding of the molecular mechanisms driving cellular responses, thus translating basic research into potential clinical applications.
This product's unique selling points include the high-quality standardization of the knockout methodology, which ensures reproducibility and reliability in experimental outcomes. Unlike traditional cell lines that express AIF1L, these knockout lines provide a clear and isolated model for studying gene function, making them essential tools in the arsenal of researchers focused on gene therapy, regenerative medicine, and pathophysiology.
For researchers and clinicians alike, the value of AIF1L Gene Knockout Cell Lines lies in their ability to streamline experimental design while providing robust models for the investigation of critical biological questions. With a commitment to excellence and extensive experience in biotechnological innovations, our company offers a wide range of genetic products designed to empower scientific discovery and drive forward the frontiers of biomedical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.